Research
Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis
Elmira Valiyeva, Nathan Herrmann, Paula A. Rochon, Sudeep S. Gill and Geoffrey M. Anderson
CMAJ August 26, 2008 179 (5) 438-446; DOI: https://doi.org/10.1503/cmaj.071540
Elmira Valiyeva PhD
Nathan Herrmann MD
Paula A. Rochon MD MPH
Sudeep S. Gill MD MSc
Geoffrey M. Anderson MD PhD
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis
Elmira Valiyeva, Nathan Herrmann, Paula A. Rochon, Sudeep S. Gill, Geoffrey M. Anderson
CMAJ Aug 2008, 179 (5) 438-446; DOI: 10.1503/cmaj.071540
Jump to section
Related Articles
Cited By...
- Public reporting of antipsychotic prescribing in nursing homes: population-based interrupted time series analyses
- Sex and gender considerations in Canadian clinical practice guidelines: a systematic review
- Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study
- Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
- Provincial Drug Plan Officials' Views of the Canadian Drug Safety System
- Concerns about health care warnings and their impact on prescribing behaviour